Docusign (NASDAQ:DOCU) Price Target Cut to $55.00 by Analysts at Robert W. Baird

Docusign (NASDAQ:DOCUFree Report) had its price target reduced by Robert W. Baird from $75.00 to $55.00 in a report issued on Wednesday morning,Benzinga reports. Robert W. Baird currently has a neutral rating on the stock.

Other research analysts have also recently issued research reports about the company. Weiss Ratings restated a “hold (c)” rating on shares of Docusign in a research report on Wednesday, January 21st. Zacks Research lowered shares of Docusign from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 24th. Royal Bank Of Canada lowered their price objective on shares of Docusign from $95.00 to $70.00 and set a “sector perform” rating on the stock in a research note on Monday, January 5th. Jefferies Financial Group downgraded shares of Docusign from a “buy” rating to a “hold” rating and dropped their target price for the company from $105.00 to $45.00 in a report on Monday, February 23rd. Finally, Evercore cut their target price on shares of Docusign from $92.00 to $80.00 and set an “in-line” rating for the company in a research report on Friday, December 5th. Five investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $66.67.

Check Out Our Latest Stock Report on DOCU

Docusign Price Performance

Shares of NASDAQ:DOCU opened at $48.90 on Wednesday. The firm has a market capitalization of $9.79 billion, a price-to-earnings ratio of 33.04, a price-to-earnings-growth ratio of 2.07 and a beta of 1.03. The business’s 50 day simple moving average is $50.69 and its 200-day simple moving average is $64.35. Docusign has a 12 month low of $40.16 and a 12 month high of $94.67.

Docusign (NASDAQ:DOCUGet Free Report) last released its quarterly earnings data on Tuesday, March 17th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.06. The firm had revenue of $836.86 million during the quarter, compared to the consensus estimate of $828.23 million. Docusign had a return on equity of 16.70% and a net margin of 9.60%.Docusign’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the business posted $0.86 EPS. On average, equities analysts anticipate that Docusign will post 1.17 earnings per share for the current year.

Docusign declared that its board has authorized a share buyback program on Tuesday, March 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the company to repurchase up to 21% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

Insider Buying and Selling

In related news, CFO Blake Jeffrey Grayson sold 6,500 shares of the stock in a transaction on Friday, January 9th. The stock was sold at an average price of $70.00, for a total transaction of $455,000.00. Following the sale, the chief financial officer owned 111,713 shares of the company’s stock, valued at $7,819,910. This trade represents a 5.50% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Allan C. Thygesen sold 26,250 shares of Docusign stock in a transaction dated Friday, January 9th. The stock was sold at an average price of $69.60, for a total value of $1,827,000.00. Following the sale, the chief executive officer owned 142,261 shares of the company’s stock, valued at approximately $9,901,365.60. This represents a 15.58% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 51,477 shares of company stock valued at $3,521,607 over the last three months. Insiders own 1.01% of the company’s stock.

Institutional Investors Weigh In On Docusign

Hedge funds and other institutional investors have recently modified their holdings of the company. Central Pacific Bank Trust Division acquired a new position in shares of Docusign in the fourth quarter valued at approximately $25,000. Modus Advisors LLC acquired a new stake in Docusign during the fourth quarter worth approximately $27,000. Torren Management LLC acquired a new stake in Docusign during the fourth quarter worth approximately $28,000. Aventura Private Wealth LLC purchased a new stake in Docusign in the 4th quarter worth approximately $30,000. Finally, True Wealth Design LLC grew its stake in Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock worth $30,000 after acquiring an additional 222 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

Docusign News Summary

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Q4 results and FY27 outlook beat estimates — DocuSign reported adjusted EPS of $1.01 and revenue of $836.9M, topping Street forecasts and signaling continued subscription growth and momentum into fiscal 2027. Docusign’s Q4 Earnings and Revenues Surpass Estimates, Increase Y/Y
  • Positive Sentiment: Share‑repurchase boost — Management authorized a $2.0 billion increase to the buyback program, a direct capital‑return action that supports EPS and signals confidence from the board. PR Newswire: Share Repurchase Increase
  • Positive Sentiment: Product traction in IAM and AI — Management highlighted strong IAM ARR (> $350M after 18 months) and plans to grow IAM share and AI partnerships, supporting secular expansion beyond e‑signatures. Seeking Alpha: IAM ARR and AI Partnerships
  • Neutral Sentiment: Analysts and investors want higher top‑line acceleration — Coverage notes that while results showed traction, many want to see sustained >10% revenue growth before committing, leaving some investors on the sidelines. MSN: Analysts Wait for 10%+ Revenue Growth
  • Neutral Sentiment: Some buy ratings remain — BTIG reaffirmed a buy with a $70 target, showing pockets of analyst optimism despite broad caution. Benzinga: BTIG Reaffirms Buy
  • Negative Sentiment: Broad downward revisions to price targets — Multiple firms (Citigroup, Morgan Stanley, JPMorgan, UBS, Wells Fargo, RBC, Piper Sandler, Baird, others) cut targets after the print, reflecting concerns about growth runway and execution; that pressure caps upside even with the beat. Blockonomi: Analyst Targets Slashed TickerReport: Citigroup Cut
  • Negative Sentiment: Valuation and growth trade‑offs highlighted — Analysts trimmed fair‑value estimates and flagged pricing/AI competition risks, underscoring why some investors remain cautious despite product progress. Yahoo Finance: Valuation and AI Risks

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Read More

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.